Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy.

Gilad, Amir; Fricker, Zachary P; Hsieh, Adam; Thomas, Dylan D; Zahorian, Toni; Nunes, David P

Gilad, Amir; Fricker, Zachary P; Hsieh, Adam; Thomas, Dylan D; Zahorian, Toni; Nunes, David P.

Afiliação

Gilad A; Boston University School of Medicine.
Fricker ZP; Evans Department of Medicine, Section of Gastroenterology.
Hsieh A; Boston University School of Medicine.
Thomas DD; Evans Department of Medicine, Section of Endocrinology, Boston University School of Medicine.
Zahorian T; Clinical Pharmacy, Boston Medical Center, Boston, MA.
Nunes DP; Evans Department of Medicine, Section of Gastroenterology.

J Clin Gastroenterol ; 53(8): 616-620, 2019 09.

Article em En | MEDLINE | ID: mdl-30614943

Assuntos

Antivirais/uso terapêutico; Diabetes Mellitus Tipo 2; Hepatite C Crônica/tratamento farmacológico; Idoso; Glicemia/metabolismo; Feminino; Hemoglobinas Glicadas/metabolismo; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google